COMMUNIQUÉS West-GlobeNewswire

ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
23/07/2026
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter [...]
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
23/07/2026
Taipei, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
23/07/2026
WILMINGTON, Del., July 23, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
23/07/2026
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b HCW11-018b has demonstrated potential for treating [...]
University of Iowa and Stride Autism Centers Partner on OSERS-Funded ICORE Project to Develop the Next Generation of Behavior Analysts
23/07/2026
Five-year initiative pairs rigorous academic preparation at the University of Iowa with intensive clinical supervision at Stride Autism Centers — building the workforce of Board Certified Behavior Analysts that Iowa [...]
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
23/07/2026
Agreement Temporarily Restricts Preferred-to-Common Stock Conversions Below a Defined Price Threshold, Mitigating Potential Near-Term Dilution GAITHERSBURG, Md., July 23, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. ( [...]
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
23/07/2026
Dr. Ascheim has over 30 years of clinical and executive experience advancing breakthrough therapies, including gene, cell, and biologics MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) a clinical [...]
Siemens Healthineers Launches an Industry-leading Menu for Core Lab Capillary Testing on Atellica Analyzers with Claims for 24 Assays
23/07/2026
Tarrytown, New York, USA, July 23, 2026 (GLOBE NEWSWIRE) -- Capillary testing is a patient-friendly option and ideal for difficult veins Capillary capability helps scale core labs’ testing offerings easily using [...]
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2026 financial results on Thursday, August 6, 2026. The company will [...]
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
23/07/2026
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing. Healthcare Holding Schweiz is managed by Winterberg [...]
Tilray Brands Launches ZONNA, Introducing New THC Pouches for Cannabis Consumers
23/07/2026
Fast-acting, smoke-free ZONNA THC pouches deliver precise dosing in a discreet, portable pouch – expanding consumer choice through continued cannabis innovation TORONTO, July 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, [...]
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
23/07/2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
23/07/2026
All-share transaction creating a combined company to operate as Scancell advancing a pipeline of targeted, off-the-shelf, active immunotherapies Combined company to be listed on Nasdaq, in addition to Scancell’s [...]
Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call
23/07/2026
ATLANTA, July 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
23/07/2026
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of care Multidisciplinary care teams, paired with always-on AI [...]
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
23/07/2026
- All eight patients enrolled and dosed in Cohort 1 ahead of previously disclosed guidance of the end of the third quarter of 2026 - - Independent Safety Monitoring Committee to review Cohort 1 safety and tolerability [...]
Sotera Health Announces Second-Quarter 2026 Earnings Release Date
23/07/2026
CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare [...]
AAVantgarde Announces Participation of Founder and CSO, Prof. Alberto Auricchio at the 32nd Annual Meeting of the Japanese Society for Gene and Cell Therapy
23/07/2026
MILAN, July 23, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced that its [...]

Pages